BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37850323)

  • 1. Regulome-wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk.
    Liu S; Zhong H; Zhu J; Wu Y; Deng Y; Wu L
    Int J Cancer; 2024 Feb; 154(4):670-678. PubMed ID: 37850323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic imbalance of chromatin accessibility in cancer identifies candidate causal risk variants and their mechanisms.
    Grishin D; Gusev A
    Nat Genet; 2022 Jun; 54(6):837-849. PubMed ID: 35697866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.
    Ünal P; Lu Y; Bueno-de-Mesquita B; van Eijck CHJ; Talar-Wojnarowska R; Szentesi A; Gazouli M; Kreivenaite E; Tavano F; Małecka-Wojciesko E; Erőss B; Oliverius M; Bunduc S; Nóbrega Aoki M; Vodickova L; Boggi U; Giaccherini M; Kondrackiene J; Chammas R; Palmieri O; Theodoropoulos GE; Bijlsma MF; Basso D; Mohelnikova-Duchonova B; Soucek P; Izbicki JR; Kiudelis V; Vanella G; Arcidiacono PG; Włodarczyk B; Hackert T; Schöttker B; Uzunoglu FG; Bambi F; Goetz M; Hlavac V; Brenner H; Perri F; Carrara S; Landi S; Hegyi P; Dijk F; Maiello E; Capretti G; Testoni SGG; Petrone MC; Stocker H; Ermini S; Archibugi L; Gentiluomo M; Cavestro GM; Pezzilli R; Di Franco G; Milanetto AC; Sperti C; Neoptolemos JP; Morelli L; Vokacova K; Pasquali C; Lawlor RT; Bazzocchi F; Kupcinskas J; Capurso G; Campa D; Canzian F
    Hum Genomics; 2024 Feb; 18(1):12. PubMed ID: 38308339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.
    Pistoni L; Gentiluomo M; Lu Y; López de Maturana E; Hlavac V; Vanella G; Darvasi E; Milanetto AC; Oliverius M; Vashist Y; Di Leo M; Mohelnikova-Duchonova B; Talar-Wojnarowska R; Gheorghe C; Petrone MC; Strobel O; Arcidiacono PG; Vodickova L; Szentesi A; Capurso G; Gajdán L; Malleo G; Theodoropoulos GE; Basso D; Soucek P; Brenner H; Lawlor RT; Morelli L; Ivanauskas A; ; Kauffmann EF; Macauda A; Gazouli M; Archibugi L; Nentwich M; Loveček M; Cavestro GM; Vodicka P; Landi S; Tavano F; Sperti C; Hackert T; Kupcinskas J; Pezzilli R; Andriulli A; Pollina L; Kreivenaite E; Gioffreda D; Jamroziak K; Hegyi P; Izbicki JR; Testoni SGG; Zuppardo RA; Bozzato D; Neoptolemos JP; Malats N; Canzian F; Campa D
    Carcinogenesis; 2021 Aug; 42(8):1037-1045. PubMed ID: 34216462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk.
    Yuan F; Hung RJ; Walsh N; Zhang H; Platz EA; Wheeler W; Song L; Arslan AA; Beane Freeman LE; Bracci P; Canzian F; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Le Marchand L; Neale RE; Rosendahl J; Scelo G; Shu XO; Visvanathan K; White E; Zheng W; Albanes D; Amiano P; Andreotti G; Babic A; Bamlet WR; Berndt SI; Brennan P; Bueno-de-Mesquita B; Buring JE; Campbell PT; Chanock SJ; Fuchs CS; Gaziano JM; Goggins MG; Hackert T; Hartge P; Hassan MM; Holly EA; Hoover RN; Katzke V; Kirsten H; Kurtz RC; Lee IM; Malats N; Milne RL; Murphy N; Ng K; Oberg AL; Porta M; Rabe KG; Real FX; Rothman N; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Wang X; Wentzensen N; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Shi J; Duell EJ; Amundadottir LT; Li D; Petersen GM; Wolpin BM; Risch HA; Yu K; Klein AP; Stolzenberg-Solomon R
    Cancer Res; 2020 Sep; 80(18):4004-4013. PubMed ID: 32641412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk.
    Tian J; Chen C; Rao M; Zhang M; Lu Z; Cai Y; Ying P; Li B; Wang H; Wang L; Li Y; Huang J; Fan L; Cai X; Ning C; Li Y; Zhang F; Wang W; Jiang Y; Liu Y; Wang M; Li H; Huang C; Yang Z; Chang J; Zhu Y; Yang X; Miao X
    Cancer Res; 2022 Jun; 82(11):2084-2096. PubMed ID: 35363263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
    Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
    Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
    Walsh N; Zhang H; Hyland PL; Yang Q; Mocci E; Zhang M; Childs EJ; Collins I; Wang Z; Arslan AA; Beane-Freeman L; Bracci PM; Brennan P; Canzian F; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman GE; Goodman PJ; Hung RJ; Kooperberg C; Kurtz RC; Malats N; LeMarchand L; Neale RE; Olson SH; Scelo G; Shu XO; Van Den Eeden SK; Visvanathan K; White E; Zheng W; ; Albanes D; Andreotti G; Babic A; Bamlet WR; Berndt SI; Borgida A; Boutron-Ruault MC; Brais L; Brennan P; Bueno-de-Mesquita B; Buring J; Chaffee KG; Chanock S; Cleary S; Cotterchio M; Foretova L; Fuchs C; M Gaziano JM; Giovannucci E; Goggins M; Hackert T; Haiman C; Hartge P; Hasan M; Helzlsouer KJ; Herman J; Holcatova I; Holly EA; Hoover R; Hung RJ; Janout V; Klein EA; Kurtz RC; Laheru D; Lee IM; Lu L; Malats N; Mannisto S; Milne RL; Oberg AL; Orlow I; Patel AV; Peters U; Porta M; Real FX; Rothman N; Sesso HD; Severi G; Silverman D; Strobel O; Sund M; Thornquist MD; Tobias GS; Wactawski-Wende J; Wareham N; Weiderpass E; Wentzensen N; Wheeler W; Yu H; Zeleniuch-Jacquotte A; Kraft P; Li D; Jacobs EJ; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Yu K; Klein AP; Stolzenberg-Solomon RZ
    J Natl Cancer Inst; 2019 Jun; 111(6):557-567. PubMed ID: 30541042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk.
    Zhong H; Liu S; Zhu J; Wu L
    Int J Cancer; 2023 Jul; 153(1):103-110. PubMed ID: 36757187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility.
    Corradi C; Gentiluomo M; Gajdán L; Cavestro GM; Kreivenaite E; Di Franco G; Sperti C; Giaccherini M; Petrone MC; Tavano F; Gioffreda D; Morelli L; Soucek P; Andriulli A; Izbicki JR; Napoli N; Małecka-Panas E; Hegyi P; Neoptolemos JP; Landi S; Vashist Y; Pasquali C; Lu Y; Cervena K; Theodoropoulos GE; Moz S; Capurso G; Strobel O; Carrara S; Hackert T; Hlavac V; Archibugi L; Oliverius M; Vanella G; Vodicka P; Arcidiacono PG; Pezzilli R; Milanetto AC; Lawlor RT; Ivanauskas A; Szentesi A; Kupcinskas J; Testoni SGG; Lovecek M; Nentwich M; Gazouli M; Luchini C; Zuppardo RA; Darvasi E; Brenner H; Gheorghe C; Jamroziak K; Canzian F; Campa D
    Int J Cancer; 2021 Jun; 148(11):2779-2788. PubMed ID: 33534179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis.
    Zhong H; Liu S; Zhu J; Xu TH; Yu H; Wu L
    Int J Cancer; 2024 Mar; 154(5):852-862. PubMed ID: 37860916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study.
    Yamazaki H; Streicher SA; Wu L; Fukuhara S; Wagner R; Heni M; Grossman SR; Lenz HJ; Setiawan VW; Le Marchand L; Huang BZ
    Cell Rep Med; 2024 Feb; 5(2):101391. PubMed ID: 38280379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in taste-related genes and risk of pancreatic cancer.
    Gentiluomo M; Lu Y; Canzian F; Campa D
    Mutagenesis; 2019 Dec; 34(5-6):391-394. PubMed ID: 31606007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.
    Obazee O; Capurso G; Tavano F; Archibugi L; De Bonis A; Greenhalf W; Key T; Pasquali C; Milanetto AC; Hackert T; Fogar P; Liço V; Dervenis C; Lawlor RT; Landoni L; Gazouli M; Zambon CF; Funel N; Strobel O; Jamroziak K; Cantù C; Malecka-Panas E; Landi S; Neoptolemos JP; Basso D; Talar-Wojnarowska R; Rinzivillo M; Andriulli A; Canzian F; Campa D
    Carcinogenesis; 2018 Mar; 39(3):360-367. PubMed ID: 29309705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
    Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
    Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer.
    Lu Y; Gentiluomo M; Lorenzo-Bermejo J; Morelli L; Obazee O; Campa D; Canzian F
    J Med Genet; 2020 Dec; 57(12):820-828. PubMed ID: 32066631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.
    Giaccherini M; Farinella R; Gentiluomo M; Mohelnikova-Duchonova B; Kauffmann EF; Palmeri M; Uzunoglu F; Soucek P; Petrauskas D; Cavestro GM; Zykus R; Carrara S; Pezzilli R; Puzzono M; Szentesi A; Neoptolemos J; Archibugi L; Palmieri O; Milanetto AC; Capurso G; van Eijck CHJ; Stocker H; Lawlor RT; Vodicka P; Lovecek M; Izbicki JR; Perri F; Kupcinskaite-Noreikiene R; Götz M; Kupcinskas J; Hussein T; Hegyi P; Busch OR; Hackert T; Mambrini A; Brenner H; Lucchesi M; Basso D; Tavano F; Schöttker B; Vanella G; Bunduc S; Petrányi Á; Landi S; Morelli L; Canzian F; Campa D
    Int J Cancer; 2023 Jul; 153(2):373-379. PubMed ID: 36451333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population.
    Bogumil D; Conti DV; Sheng X; Xia L; Shu XO; Pandol SJ; Blot WJ; Zheng W; Le Marchand L; Haiman CA; Setiawan VW
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2686-2692. PubMed ID: 32958499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of breast cancer associated variants that modulate transcription factor binding.
    Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
    PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.